MSC-EVs from MM patients express high levels of IL6, CCL2, and fibronectin and low levels of the tumor suppressor mir15a, which is capable of inhibiting MM cell growth but also to induce apoptosis, which maintains the disease in a stable state [59]. The gene discussed is CCL2; the disease is Miyoshi myopathy.